We searched PubMed and Current Contents Life Sciences for English and French publications using the keywords HIV infections, female, prevention and control, all child, disease transmission and vertical, foster home care, and orphans; and obtained further information from abstracts of scientific meetings, the internet, and personal communications with scientists.
AIDS in AfricaHIV-1/AIDS and maternal and child health in Africa
Section snippets
HIV-1/AIDS in women
In Africa, 55% of HIV-1-positive adults are women, all of child-bearing age.2 Data from antenatal clinics show that in several parts of southern Africa, more than 30% of pregnant women are infected with HIV-1.9 The fastest growth has been in South Africa, where the prevalence of infection in adults increased from 1% in 1990, to 25% in 2000. In west Africa, the adult rate exceeds 5% in Burkina Faso, Cameroon, Côte d'Ivoire, Nigeria, and Togo. Incidence of HIV-1 infection in Uganda, especially in
Prevention of mother-to-child transmission of HIV-1 infection
Mother-to-child transmission of HIV-1 can occur during pregnancy, delivery, and post-partum through breastfeeding. In observational cohort studies, the cumulative rates of transmission are between 25% and 45% of all children born to HIV-1-infected mothers in Africa compared with 10–30% in more-developed countries. This difference is greatly but not totally accounted for by the risk of postnatal transmission in populations in which breastfeeding is common.30
The risk of intrauterine transmission
HIV-1/AIDS in children
More than 95% of HIV-1-infected children acquired their infection from their mother: 700 000 will have become infected in 2001 and 500 000 will have died from HIV-1/AIDS.9 In stark contrast with children everywhere else in the world, children in southern Africa have a shorter life expectancy than their grandparents.68 In Zimbabwe, 70% of deaths in children younger than 5 years are due to AIDS.9 Mortality is estimated at 26–45% by the first birthday and 35–59% at 2 years.69, 70, 71, 72 Few
Prevention of mother-to-child transmission in practice and integrated care for the family
Research findings already provide a strong rationale for implementation of prevention of mother-to-child transmission interventions in resource-poor countries, especially in Africa.4, 5, 6 WHO regularly reviews data and considers all antiretroviral regimens of validated efficacy as possible options in the minimum package of care that must be provided for HIV-1-positive women and their children, and not restricted to pilot projects or research settings.77 Drug(s) should be chosen according to
Orphanhood and HIV-1/AIDS
Historically, largescale orphaning has been a sporadic, short-term problem caused by war, famine, or disease. HIV-1/AIDS has transformed it into a long-term chronic problem that will worsen in coming decades.93 More than 15·6 million children have lost their mother or both parents to AIDS or related causes worldwide. The 12·1 million African children who had lost their mother or both parents to the epidemic by the end of 2001 is forecast to more than double during the next decade.9 9% of
Conclusions
Mother-to-child transmission is largely preventable with interventions that are readily accessible to resource-poor countries: prevention of sexual transmission of HIV-1 for women of childbearing age, especially very young women; access to HIV-1 testing and reduction of unwanted pregnancies by HIV-1-infected women informed of their serostatus; and antiretroviral-based prevention of motherto-child transmission. Prevention of mother-to-child transmission is the most cost-effective antiretroviral
Search strategy and selection criteria
References (100)
- et al.
Advances and research directions in the prevention of mother-to-child HIV-1 transmission
Lancet
(2000) - et al.
Population-based study of fertility in women with HIV-1 infection in Uganda
Lancet
(1998) - et al.
Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial
Lancet
(2001) - et al.
International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection
Lancet
(1998) - et al.
Influence of infant feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study
Lancet
(1999) - et al.
Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission
Lancet
(1996) - et al.
Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda
Am J Obstet Gynecol
(2001) - et al.
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial
Lancet
(1999) - et al.
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine in reducing vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial
Lancet
(1999) - et al.
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
Lancet
(1999)
Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV
Lancet
Policy implications of the inadequate support systems for orphans in western Kenya
Health Policy
Mothers, orphans, and prevention of paediatric AIDS
Lancet
Final declaration of commitment on HIV/AIDS (A/s-26/L.2). New York
Global situation of the HIV/AIDS pandemic, end 2001: part I
Wkly Epidemiol Rec
Child health research: a foundation for improving child health (WHO/FCH/CAH/02.3)
Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice
JAMA
Prevention of mother-to-child transmission of HIV in developing countries: recommendations for practice
Health Policy Plann
Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000
AIDS
Prevention of infectious complications of paediatric HIV infection in Africa
AIDS
AIDS epidemic update December 2001 (UNAIDS/01.74E-WHO/CDS/CSR/NCS/2001.2)
Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda
AIDS
Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection
J Infect Dis
Four years of natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 1988–1993
J Acquir Immune Defic Syndr
β-2 microglobulin as a predictor of death in HIV-infected women from Kigali, Rwanda
AIDS
An HIV-1 natural history cohort and survival times in rural Uganda
AIDS
Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study
BMJ
Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Côte d'Ivoire, 1997–2000
J Acquir Immune Defic Syndr
Natural history and spectrum of disease in adults with HIV/AIDS in Africa
AIDS
Impaired fertility in HIV-1 infected pregnant women: a clinic based survey in Abidjan, Côte d'Ivoire, 1997
AIDS
Decreased fertility among HIV-1 infected women attending antenatal clinics in three African cities
J Acquir Immune Defic Syndr
Incidence of pregnancies among African HIV-infected women, Abidjan, 1995–2000
AIDS
Sexual and reproductive life of women informed of their HIV seropositivity: a prospective cohort study in Burkina Faso
J Acquir Immune Defic Syndr
HIV counseling and testing of pregnant women in sub-Saharan Africa-experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania
J Acquir Immune Defic Syndr
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial
JAMA
Are HIV-infected women who breast-feed at increased risk of mortality?
AIDS
Effect of breastfeeding on mortality among HIV-infected women
Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results from 13 perinatal studies
J Acquir Immune Defic Syndr Hum Retrovirol
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
N Eng J Med
Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission
J Infect Dis
Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial
AIDS
HIV transmission through breastfeeding—a study in Malawi
JAMA
Infant feeding and HIV-1 infection
AIDS
Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology
Stat Med
Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa
AIDS
Collection of standardized information on infant feeding in the context of mother-to-child transmission of HIV
Stat Med
HIV and infant feeding—a guide for health-care managers and supervisors
New data on the prevention of mother-to-child transmission of HIV and their policy implications
Cited by (174)
Altruism in preventive health behavior: At-scale evidence from the HIV/AIDS pandemic
2018, Economics and Human BiologyChild Developmental Trajectories in Adversity: Environmental Embedding and Developmental Cascades in Contexts of Risk
2018, Understanding Uniqueness and Diversity in Child and Adolescent Mental HealthChild mortality risk and fertility: Evidence from prevention of mother-to-child transmission of HIV
2015, Journal of Development EconomicsCitation Excerpt :Antiretroviral drugs appear to be particularly important. Combination therapy (i.e., zidovudine (ZDV) and nevirapine (NVP)) administered at the three stages at which MTCT may occur virtually eliminates MTCT (Canning, 2006; Dabis and Ekpini, 2002). Single-dose NVP administered at these three stages reduces MTCT by 10 to 25 percentage points (Guay et al., 1999; Jackson et al., 2003).19
Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: A review of emerging challenges
2014, The Lancet Infectious DiseasesCitation Excerpt :Of more than three million children infected with HIV, 90% live in sub-Saharan Africa.1 The advent of the HIV epidemic resulted in a reversal of the improvements recorded in child health outcomes in the 1970s and 1980s, with global child mortality rates a third to two-thirds higher than they would have been in the absence of HIV/AIDS.2 However, since 2004, access to paediatric antiretroviral treatment has expanded globally, resulting in a substantial decline in mortality rates in HIV-infected children.3
HIV in pregnancy
2021, Contemporary Obstetrics and Gynecology for Developing Countries: Second Edition